2672: A Primer on REMS and the New Era at FDA
2785: FDA Science and Mission at Risk
3009: Regulatory Best Practices for Emerging Companies & First-Time Filers
3056: Policy Developments in Pharmacogenomics Diagnostic Regulation — Case Studies from Australia, Europe and the United States
3104: Is Gaining Drug Approval More Difficult in Europe Than the US, or Vice Versa?
3315: FDA Amendments Act (FDAAA) of 2007: Implementation, Effects on Innovation, and the Impending Debate on "PDUFA V."
3900: FDA Town Hall
3901: EMEA/FDA Town Hall